ACXP
Acurx Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.14
+3.64%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$0.45
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$0.53
- EPS estimate
- -$0.38
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -130991.8%
- Revenue beats (12Q)
- —
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 14, 2026 | -$0.38 | -$0.53 | Miss -40.71% | — |
| May 12, 2026 | -$0.59 | -$0.62 | Miss -5.08% | — |
| Mar 13, 2026 | -$1.01 | -$5.3K | Miss -523945.15% | — |
| Nov 12, 2025 | -$1.61 | -$1.23 | Beat 23.60% | — |
| Mar 17, 2025 | -$0.18 | -$0.16 | Beat 11.11% | — |
| Aug 9, 2024 | -$0.28 | -$0.26 | Beat 7.14% | — |
| Mar 15, 2024 | -$0.26 | -$0.38 | Miss -46.15% | — |
| Nov 13, 2023 | -$0.28 | -$0.24 | Beat 14.29% | — |
| Aug 14, 2023 | -$0.29 | -$0.28 | Beat 3.45% | — |
| May 12, 2023 | -$0.34 | -$0.25 | Beat 26.47% | — |
| Mar 16, 2023 | -$0.25 | -$0.28 | Miss -12.00% | — |
| Nov 14, 2022 | -$0.28 | -$0.32 | Miss -14.29% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026